CENTER FOR DISEASE DYNAMICS ECONOMICS & POLICY INC
Programs
Oxygen For India Initiative
OXYGEN FOR INDIA:THE OXYGEN FORINDIA INITIATIVE INITIATED AT THE HEIGHT OF THE UNPRECEDENTED OXYGENCRISIS IN APRIL 2021. LED BY DR. RAMANAN LAXMINARAYAN, ECONOMIST, EPIDEMIOLOGIST, AND FOUNDER AND PRESIDENT OF THE ONE HEALTH TRUST (FOUNDED AS THE CENTER FOR DISEASEDYNAMICS, ECONOMICS & POLICY OR CDDEP), OXYGENFORINDIA IS A COLLECTIVE EFFORT OFPHILANTHROPIC ORGANIZATIONS, CORPORATIONS, MEDICAL AND PUBLIC HEALTH PROFESSIONALS,VOLUNTEERS, AND CONCERNED CITIZENS AROUND THE WORLD. MANY PARTNERS AND NEARLY 14,000SMALL AND LARGE DONORS RANGING FROM STUDENTS RAISING MONEY FROM THEIR FRIENDS TOLOGITECH, UIPATH, VISTA EQUITY PARTNERS, FACEBOOK, GIVE FOUNDATION, AND MORE CAMETOGETHER TO HELP SUPPORT OXYGENFORINDIAS WORK. THE INITIATIVE PERSISTS WITH ALONG-TERM VISION TO ENSURE THAT NO ONE IN INDIA DIES DUE TO A LACK OF MEDICAL OXYGEN.GeographiesNot indicatedDatesJan 1, 2024 – Dec 31, 2024Source990No causes providedNo populations provided–$1.5MAntibiotic Resistance Awareness
ANTIBIOTIC RESISTANCE:CDDEP VIEWS ANTIBIOTIC EFFECTIVENESS AS A SHARED RESOURCE: USING AN ANTIBIOTIC NOWINCREASES THE OPPURTINITY FOR BACTERIA TO DEVELOP RESISTANCE AND THUS REDUCES OURABILITY TO USE THAT ANTIOBIOTIC IN THE FUTURE. ADDRESSING ANTIOBITIC RESISTANCE ISDIFFUCULT BECAUSE PATIENTS,PHYSICIANS,HOSPITALS,PHARMACEUTICAL COMPANIES,ANDAGRICULTURAL USERS HAVE INSUFFICIENT INCENTIVES TO ACT IN WAYS THAT WOULD CONSERVEANTIBIOTIC EFFECTIVENESS.GeographiesNot indicatedDatesJan 1, 2024 – Dec 31, 2024Source990No causes providedNo populations provided–$1.1MModeling Infectious Diseases in Healthcare
Modeling Infectious Diseases in Healthcare Network (MInD Healthcare):THE MODELS DEVELOPED THROUGH THIS PROPOSAL WILL IMPROVE UNDERSTANDING OF HOWBIOLOGICAL FACTORS ASSOCIATED WITH THE TRANSMISSION OF MULTIDRUG-RESISTANT ORGANISMS(MDRO) IMPACT INTERVENTIONS TO REDUCE HOSPITAL-ASSOCIATED INFECTIONS (HAIS). THISWILL AID PREDICTIONS OF PATIENTS RISK FOR COLONIZATION AND INFECTION, AS WELL ASIMPROVE UNDERSTANDING OF HOW INTERVENTIONS CAN MOST EFFECTIVELY BE COMBINED TO REDUCE THE LIKELIHOOD THAT PATIENTS WILL SUFFER FROM THESE HIGH-CONSEQUENCE PATHOGENS.GeographiesNot indicatedDatesJan 1, 2024 – Dec 31, 2024Source990No causes providedNo populations provided–$635.1K
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)